Corlanor and Appetite - decreased - a phase IV clinical study of FDA data

Summary:

Appetite - decreased is reported as a side effect among people who take Corlanor (ivabradine hydrochloride), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Tylenol, and have Nausea.

The phase IV clinical study analyzes which people have Appetite - decreased when taking Corlanor. It is created by eHealthMe based on reports of 2,372 people who have side effects when taking Corlanor from the FDA, and is updated regularly.

What is Corlanor?

Corlanor has active ingredients of ivabradine hydrochloride. eHealthMe is studying from 2,453 Corlanor users. Check the latest studies of Corlanor.

What is Appetite - decreased?

Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat) is found to be associated with 3,574 drugs and 4,588 conditions by eHealthMe. Check the latest studies of Appetite - decreased.

On Jul, 09, 2026

2,372 people reported to have side effects when taking Corlanor.
Among them, 22 people (0.93%) have Appetite - decreased.

Could Corlanor cause Appetite - decreased?

Among these 22 people:

How long have people been on Corlanor when they have Appetite - decreased? *

What is the gender of people who have Appetite - decreased when taking Corlanor? *

female: 80.95 %
male: 19.05 %

What is the age of people who have Appetite - decreased when taking Corlanor? *

What are other drugs people take besides Corlanor? *

What are other side effects people have besides Appetite - decreased? *

Dyspnea (difficult or laboured breathing): 10 people, 45.45%
Constipation: 10 people, 45.45%
Visual Impairment: 10 people, 45.45%
Chest Pain: 10 people, 45.45%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 10 people, 45.45%
Atelectasis (partial or complete collapse of the lung): 9 people, 40.91%
Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium): 9 people, 40.91%
Heart Rate Irregular: 9 people, 40.91%
Pleural Effusion (water on the lungs): 9 people, 40.91%
Flank Pain (a distressing sensation experienced around the lower back and the upper abdomen): 9 people, 40.91%

What are the existing conditions these people have? *

Pain: 9 people, 40.91%
Nausea (feeling of having an urge to vomit): 9 people, 40.91%
Agitation (state of anxiety or nervous excitement): 7 people, 31.82%
Stress And Anxiety: 5 people, 22.73%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 18.18%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 18.18%
Sleep Disorder: 2 people, 9.09%
Sinus Tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node): 2 people, 9.09%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.09%
Cardiac Failure Chronic: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Corlanor and have Appetite - decreased?

- Check whether Appetite - decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Corlanor:

Corlanor (2,453 reports)

Browse all side effects of Corlanor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Appetite - decreased:

Appetite - decreased (3,574 drugs)

Browse all the conditions that are associated with Appetite - decreased:

Appetite - decreased (4,588 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ivabradine hydrochloride (the active ingredients of Corlanor) and Corlanor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.